all report title image

BIOSIMULATION MARKET ANALYSIS

Biosimulation Market, By Product and Services (Software and Services), By Application (Drug Discovery and Drug Development), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies and Online Pharmacies), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)

  • Published In : Jan 2024
  • Code : CMI2016
  • Pages :159
  • Formats :
      Excel and PDF
  • Industry : Healthcare IT

Market News

Global Biosimulation Market- Recent Developments

New Product Launches

  • For instance, in 2022, Certara, a global manufacturer of biosimulation software, announced the release of new versions of its Immunogenicity (IG), Immuno-oncology (IO) and Vaccine Simulators to predict how drugs work and address key questions in the development of novel biologic therapies
  • For instance, in 2020, 54gene, a Nigeria-based health tech precision medicine research company, launched its Clinical Research Programme Services (CPS) division. The new business division will provide end-to-end clinical development services, intelligence, logistics, and infrastructure to enable the conduct of clinical trials in Africa, starting out of Nigeria
  • In 2022, Dante Labs, a global provider of genomic information and precision medicine, announced new genomic driven biosimulation and significant progress made to its drug discovery program, demonstrating the value of the Dante Platform

Acquisition and Partnerships

  • In 2022, Cadence Design Systems, Inc., an multinational computational software company, entered into a definitive agreement to acquire privately held OpenEye Scientific Software, Inc., a provider of computational molecular modeling and simulation software being widely and increasingly used by pharmaceutical and biotechnology companies for drug discovery
  • In 2021, CATO SMS, a global provider of regulatory and clinical research services, announced that it had acquired Nuventra, Inc. to extend its offering into the critical area of clinical pharmacology. Nuventra is one of the industry’s leading clinical pharmacology science and services providers.  The acquisition expanded CATO SMS’ portfolio of specialized solutions that support biopharmaceutical companies with drug development, adding a key set of capabilities focused on significantly reducing development risk, costs and timelines.

Need a Custom Report?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports

Customize Now
Logo

Credibility and Certifications

ESOMAR
DUNS Registered
Clutch
DMCA Protected

9001:2015

Credibility and Certifications

27001:2022

Credibility and Certifications

EXISTING CLIENTELE

Joining thousands of companies around the world committed to making the Excellent Business Solutions.

View All Our Clients
trusted clients logo
© 2024 Coherent Market Insights Pvt Ltd. All Rights Reserved.